Wednesday, November 23, 2011

Strategic Analysis

!±8± Strategic Analysis

What is The BCG Growth-Share Matrix? What are the main aspects of The BCG Growth-Share Matrix? How to develop Good BCG Growth-Share Matrix of a company? Where to find information for The BCG Growth-Share Matrix?

INTRODUCTION
No strategic management or marketing text appears to be complete without the inclusion of the Boston Consulting Group (BCG) growth-share matrix. When used effectively, this model provides guidance for resource allocation. And despite its inherent weaknesses, is probably one of the most widely used management instrument as far as portfolio management is concern. For instant, each SBU (strategic business unit) of large companies such as General Electric, Siemens, and Centrica require different strategies to compete effectively and efficiently. It is not a question of one strategy fits all SBUs since the likelihood for each of them experiencing the same market growth rate, industry-threats and leverage is very slim. This is where the BCG model comes into play as a management analytical tool. The ensuing examines the underpinnings of the model, for what it is used, how to use it and why it is used.

WHAT IS THE BCG GROWTH-SHARE MATRIX?
To begin with, BCG is the acronym for Boston Consulting Group-a general management consulting firm highly respected in business strategy consulting. BCG Growth-Share Matrix (see figure 1) happens to be one of many of BCG's strategic concepts the organisation developed in the late 1970s, and is being taught at leading business schools and executive education programmes around the world.

It is a management tool that serves four distinct purposes (McDonald 2003; Kotler 2003; Cipher 2006): it can be used to classify product portfolio in four business types based on four graphic labels including Stars, Cash Cows, Question Marks and Dogs; it can be used to determine what priorities should be given in the product portfolio of a company; to classify an organisation's product portfolio according to their cash usage and generation; and offers management available strategies to tackle various product lines. Consider companies like Apple Computer, General Electric, Unilever, Siemens, Centrica and many more, engaging in diversified product lines. The BCG model therefore becomes an invaluable analytical tool to evaluate an organisation's diversified product lines as later seen in the ensuing sections.

WHAT ARE THE MAIN ASPECTS OF THE BCG GROWTH-SHARE MATRIX?
The BCG Growth-Share Matrix is based on two dimensional variables: relative market share and market growth. They often are pointers to healthiness of a business (Kotler 2003; McDonald 2003). In other words, products with greater market share or within a fast growing market are expected to wield relatively greater profit margins. The reverse is also true. Let's look at the following components of the model:
Fig. 1: Source: 12manage.com 2006

Relative Market Share
According to the proponents of the BCG (Herndemson 1972), It captures the relative market share of a business unit or product. But that is not all! It allows the analysed business unit be pitted against its competitors. As earlier emphasized above, this is due to the sometime correlation between relative market share and the product's cash generation. This phenomenon is often likened to the experience curve paradigm that when an organisation enjoys lower costs, improved efficiency from conducting business operations overtime. The basic tenet of this postulation is that the more an organisation performs a task often; it tends to develop new ways in performing those tasks better which results in lower operating cost (Cipher 2006). What that suggests is that the experience curve effect requires that market share is increased to be able to drive down costs in the long run and at the same time a company with a dominant market share will inevitably have a cost advantage over competitor companies because they have the greater share of the market. Hence, market share is correlated with experience.

A case in point is Apple Computer's flagship product called the iPod, which occupies a dominant 73% share the portable music player market (Cantrell 2006). Analysts believe it is the impetus for Apple's financial rebirth 40% of Apple's sales is attributed to the iPod product line (Cantrell 2006). Similarly, Dell's PC line shares the same market dominance theory as the iPod. The PC manufacture giant occupies a worldwide market share of 18.1%, which is commensurate to its large market revenue above its competitors (see figure 2).
Figure 2: Source: Reuters 2006

Market Growth
Market growth axis, correlates with the product life cycle paradigm, and predicates the cash requirement a product needs relative to the growth of that market. A fast growing market is generally considered attractive, and pulls a lot of organisation's resources in an effort to increase gains. A case in point is the technological market widely consider by experts as a fast growing market, and tends to attract a lot of competition. Therefore, a product life cycle and its associated market play a key role in decision-making.

Cash Cows
These products are said to have high profitability, and require low investment for the fact that they are market leaders in a low-growth market. This viewpoint is captured by the founders themselves thus:

The cash cows fund their own growth. They pay the corporate dividend. They pay the corporate overhead. They pay the corporate interest charges. They supply the funds for R&D. They supply the investment resource for other products. They justify the debt capacity for the whole company. Protect them (Henderson 1976).

According to experts (Drummond & Ensor 2004; Kotler 2003; McDonald 2003), surplus cash from cash cow products should be channelled into Stars and Questions in order to create the future Cash Cows.

Stars
Stars are leaders in high growth markets. They tend to/should generate large amounts of cash but also use a lot of cash because of growth market conditions. For example, Apple Computer has a large share in the rapidly growing market for portable digital music players (Cantrell 2006).

Question Marks
Question Marks have not achieved a dominant market position, and hence do not generate much cash. They tend to use a lot of cash because of growth market conditions. Consider Hewlett-Packard's small share of the digital camera market, behind industry leader Canon's 21% (Canon 2006). However, this is a rapidly growing market.

Dogs
Dogs often have little future and are big cash drainers on the company as they generate very little cash by virtue of their low market share in a highly low growth market.
Consider Pfizer's Inspra (Gibson 2006):

"Pfizer launched this drug in Q4 2003 and continues to pump money into this problem child, despite anaemic sales of roughly million in the .7 billion heart-failure market dominated by Toprol-XL (metoprolol). It was thought to gain market share and become a star, and eventually a cash cow when the market growth slowed. But, according to industry's experts, Inspra is likely to remain a dog, despite any amount of promotion, given its perceived safety issues and a cheaper, more effective spironolactone in the same Pfizer portfolio. Because Pfizer invested heavily in promotion early on with Inspra, the drug's earnings potential and positive cash flow is elusive at best. A portfolio analysis of Pfizer's cardiovascular franchise would suggest redeploying promotional spend on Inspra to up-and-coming stars like Caduet (amlodipine/atorvastatin) or torcetrapib to ensure those drugs reach their sales potential."

HOW TO DEVELOP GOOD BCG GROWTH-SHARE MATRIX OF A COMPANY?
SBUs or products are represented on the model by circles and fall into one of the four cells of the matrix already described above. Mathematically, the mid-point of the axis on the scale of Low-High is represented by 1.0 (Drummond & Ensor 2004; Kotler 2003). At this point, the SBU's or product's market share equals that of its largest competitor's market share (Drummond & Ensor 2004; Kotler 2003). Next, calculate the relative market share and market growth for each SBU and product. Figure 3 depicts the formulas to calculate the relative market share and market growth.
Fig 3

Oftentimes, if you are versed with a particular industry and companies operating in it, you could draw up a BCG matrix for any company without necessarily computing figures for the relative market share and market growth. Figure 4 depicts a fairly accurate BCG growth-share matrix for Apple Computer developed in the spring of 2005 without the author calculating the relative market share and market growth.
Fig. 4 Source: Asong (2005)

Once the products or SBUs have been plotted, the planner then has to decide on the objective, strategy and budget for the business lines. Basically, at this juncture the organisations should strive to maintain a balanced portfolio. Cash generated from Cash Cows should flow into Stars and Question Marks in an effort to create future Cash Cows. Moreover, there are 4 major strategies that can be pursued at this stage as described in the ensuing section.

AVAILABLE STRATEGIES TO PURSUE

Build
The product or SBU's market share needs to be increased to strengthen its position. Short-term earnings and profits are deliberately forfeited because it is hoped that the long-term gains will be higher than this. This strategy is suited to Question Marks if they are to become stars.

Hold
The objective is to maintain the current share position and this strategy is often used for Cash Cows so that they continue to generate large amounts of cash.

Harvest
Here management tries to increase short-term cash flows as far as possible (e.g. price increase, cutting costs) even at the expense of the products or SBU's longer-term future. It is a strategy suited to weak Cash Cows or Cash Cows that are in a market with a limited future. Harvesting is also used for Question Marks where there is no possibility of turning them into Stars, and for Dogs.

Divest
The objective of this strategy is to rid the organisation of the products or SBUs that are a drain on profits and to utilize these resources elsewhere in the business where they will be of greater benefit. This strategy is typically used for Question Marks that will not become Stars and for Dogs.

WHERE TO FIND INFORMATION FOR THE BCG GROWTH-SHARE MATRIX?
Information for the BCG Growth-Share matrix is generated from multiple sources including company's annual reports, sec fillings and a host of specialised research organisations such as IDC, Hoover, Edgar, Forrester and many more. Armed with this information, developing a BCG growth-share matrix should pose less of a problem.

Limitations
The BCG model is criticised for having a number of limitations (Kotler 2003; McDonald 2003):

o There are other reasons other than relative market share and market growth that could influence the allocation of resources to a product or SBU: reasons such as the need for strong brand name and product positioning could compel resource allocation to an SBU or product (Drummond & Ensor 2004).

o What is more, the model rests on net cash consumption or generation as the fundamental portfolio balancing criterion. That is appropriate only in a capital constrained environment. In modern economies, with relatively frictionless capital flows, this is not the appropriate metric to apply - rather, risk-adjusted discounted cash flows should be used (ManyWorlds 2005).

o Also, the matrix assumes products/business units are independent of each other, and independent of assets outside of the business. In other words, there is no provision for synergy among products/business units. This is rarely realistic.

o The relationship between cash flow and market share may be weak due to a number of factors including (Cipher 2006): competitors may have access to lower cost materials unrelated to their relative share position; low market share producers may be on steeper experience curves due to superior production technology; and strategic factors other than relative market share may affect profit margins.

o In addition, the growth-share matrix is based on the assumption that high rates of growth use large cash resources and that maturity of the life cycle brings about the expected profit returns. This may be incorrect due to various reasons (Cipher 2006): capital intensity may be low and the business/product could be grown without major cash outlay; high entry barriers may exist so margins may be sustainable and big enough to produce a positive cash flow and a growth at the same time; and industry overcapacity and price competition may depress prices in maturity.

o Furthermore, market growth is not the only factor or necessarily the most important factor when assessing the attractiveness of a market. A fast growing market is not necessarily an attractive one. Growth markets attract new entrants and if capacity exceeds demand then the market may become a low margin one and therefore unattractive. A high growth market may lack size and stability.
Given the aforementioned weaknesses, the BCG Growth-Share matrix must be used with care; nonetheless, it is a best-known business portfolio evaluation model (Kotler 2003).

If you found this article useful please have a look at the other articles we have written: PEST analysis, Porter's 5 Forces analysis, Ansoff analysis, SWOT analysis, Porter's Generic Strategies, Scenario Planning, Value chain analysis.

REFERENCE
12Management (2006). BCG Matrix. www.12management.com [Accessed: September 23, 2006]
Asong, B. (2005). Case Study: Apple Computer Market Assessment and Product Launch Strategy. CLC-PHW: London, pp. 17-40.
BCG (2006). The Growth-Share Matrix. www.bcg.com [Accessed: September 20, 2006]
Canon (2006). InfoSource research puts Canon No.1 in the UK & Ireland. [Accessed: September 28, 2006]
Cantrell, A. (2006). Apple's Remarkable Comeback Story. [Accessed: September 28, 2006]
Drummond, G. & Ensor, J. (2004). Strategic Marketing: Planning & Control. 2nd Ed. Butterworth-Heinemann: MA, pp. 96-100.
Henderson, B. (1976). Anatomy of the Cash Cow. Accessed: September 21, 2006]
Lane, S. (2006). Overall Mac OS usage market share declining? [Accessed: September 28, 2006] http://www.appleinsider.com/article.php?id=2059
ManyWorlds (2005). Models and Concepts.[Accessed: September 24, 2006]
McDonald, M. (2003). Marketing Plans: How To Prepare Them, How To Use Them. MA: Butterworth-Heinemann, pp. 175-245.
MindTools (2006). The Boston Matrix. www.mindtools.com/pages/article/newTED_97.htm [Accessed: September 28, 2006]

BIBLIOGRAPHY
Cooper, R. G., Edgett, S. J., & Kleinschmidt, E.J. (2006). Portfolio Management. Working Paper No 12: The Product Development Institute.
Lee, C. K. (2004). Asia Zirconium Limited Valuation report. Prudential Tower: Standard & Poor's.
Vriens, D (2004). The Role of Information and Communication Technology in Competitive Intelligence. Idea Group Inc: University of Nijmegen.
Zolkiewski, J. & Turnbull, P. (undated). Relationship Portfolios-Past, Present & Future.


Strategic Analysis

Discounted Home Theatre Sound Bars

Saturday, November 19, 2011

The Truth About Hair Loss: Male Pattern Baldness

!±8± The Truth About Hair Loss: Male Pattern Baldness

Male Pattern Baldness

On average, there are 90,000 to 150,000 hairs on the scalp. The hairs grow from roots called follicles. Blood vessels at the base of each follicle provide nourishment vital for hair and hair growth. Hair growth in each root occurs in a cycle independent of each other. At any time about 90 percent of the hairs on the scalp are in the growth phase, while the other 10 percent are in the resting phase. The growth phase can last an average of up to five years, after which the follicle goes into a resting phase, which can last upto four months. At the end of this phase, the hair falls out and is replaced by a new hair. This is all a perfectly normal part of the growth cycle. In fact, on a typical day, up to 150 hairs can be lost. Baldness occurs when hair is lost at an unusually high rate and hair replacement occurs at an
unusually slow rate and/or when normal hairs are replaced by weaker, smaller ones.

What is Male Pattern Baldness?

Almost all cases of hair loss is the result of Male pattern baldness (or androgenetic alopecia).Male pattern baldness occurs much more frequently in men than in women.Even in mild cases It affects roughly 50 million men in the United States. Balding may begin at any age after puberty. While some types of hair loss is reversible, male pattern baldness tends to be permanent. It occurs in a very typical pattern on the scalp.Hair loss usually begins at the temples and at the top of the head toward the back, causing a receding hairline and a bald spot.Sometimes progressing further until the two sections become joined,leaving a horseshoe pattern on the sides and back of the head.Male pattern baldness progresses slowly and is not associated with any physical discomfort.

What causes male pattern baldness?

Male pattern baldness is thought to be a combination of hormonal and genetic factors.Testosterone and its more potent derivative dihydrotestosterone (DHT) are the contributimg factors of the degree of balddness. Whatever the exact causes of male pattern baldness may be, it is hereditary. A tendency toward baldness on either side of a man's family(mother or father) indicates The speed, pattern,and degree of the balding. Usually, the earlier it begins, the more severe the hair loss will be.
Balding is not caused by wearing a hat,you cant regrow hair by Massaging or brushing,or excessive shampooing stimulate hair growth.These are thought to be false.Stress may contribute to a form of hair loss,but normal everyday stress does not contribute to balding

What are the treatment options for male pattern baldness?

-Herbal Shamppos

-Herbal Remedies

-Specialty Shampoos(for example Helsinki Formula)

-Wigs

-Transplants

-Medication(Propecia,Minoxidil etc)

-Home Remedies

-Others

Hair transplantation

In hair transplants,healthy live follicles are removed from a donor site on the scalp and transplanted to the balding area. The follicles are commonly taken in "plugs" of one hair to two hairs (micrografts) from the sides or back of the head and moved to the balding area, with the hairline being slowly reconstructed. Larger plugs may be used. Donor sites with full hair make transplants more successful.Some scarring may occur. Transplanted follicles are usually permanent. Synthetic hair has also been used for transplants but has been known for to have a high rate of infection and has been been banned.As with any surgical procedure, hair transplantation present certain risks.If you are considering a transplant, consult your doctor.

Wigs

A hairpiece can be custom made to cover a balding area. Hairpieces may fade and over time. It is important to clean the scalp under the hairpiece regularly.Another option is a weave, in which fake(synthetic) hair is sewn into existing hair.

This just a quick run down of what happens when most men reach a certain age. Here are a couple of sites that we have found that will educate and inform and give you everything you want to know about Male Pattern Baldness. The reviews are very positive and even might give you possible solutions to this problem that has afflicted almost every man for generations.


The Truth About Hair Loss: Male Pattern Baldness

Cheaper Turntable Belts Purchasing Mikey Blue Microphone Last Minute Installation Spa

Saturday, November 5, 2011

Ubiquinol a Breakthrough For People With Heart Disease, Liver Damage, And Cancer Concerns

!±8± Ubiquinol a Breakthrough For People With Heart Disease, Liver Damage, And Cancer Concerns

The most commonly recognized supplemental for of CoQ10 has been known as "ubiquinone" or "coenzyme Q10"  Now, Japan's largest producer of CoQ10, has found a way to stabilize a pure and BIO-IDENTICAL form of the nutrient.  It is called ubiquinol, and it's the downline metabolite of CoQ10.  In other words, it's the biologically ACTIVE version of CoQ10 so it's stronger, and it slips right into your cells.  There is no need to worry about whether or not your body (and your gut) can convert the CoQ10 to it's active form (ubiquinol). This is REALLY IMPORTANT:

As you age, not only do you produce less CoQ10, but your body becomes less efficient at converting CoQ10 to the active form - Ubiquinol

Certain people have a real hard time converting the CoQ10 to ubiquinol, especially people with diabetes, GI problems, autoimmune disorders, and those with heart disease.  So ubiquinol would be ideal for people who fit in this group.  But because you get higher plasma concentrations with ubiquinol, I recommend it for everyone.  It's definitely new and improved and worth it becuase ubiquinol is a powerful antioxidant that nourishes your muscle cells.  It can help you with leg cramps, especially those related to the drug mugging effect of your medications (see below).  It can improve the look of your skin, it can improve liver function and detoxification.  It can increase ATP in the cells, so it's an energizing molecule...it's great for fatigue and low thyroid!!! 

There are hundreds of medications which could be slowly stealing the life out of you. I believe that when a drug steals a nutrient, you will develop a new symptom.  You may not realize that your new symptom is related to a drug-nutrient depletion. Please consider all the reasons why you might not be feeling as good as you used to, it's not always black and white, and based on some lab result.  If you are weak and tired, it may be your blood pressure medicine, or your statin, or your hormones, you'll see these drugs on the list below. 

There Are Absurdly Inexpensive Way to Feel Better

The subject of vitamins, minerals and nutrients is explored in-depth in Drug Muggers, which explains to you how to feel better when you develop a symptom (so you don't have to start yet another new drug!!!)  Wouldn't that be wonderful?  If you knew what medicines were depleting a nutrient, you could quickly fix that deficiency and hopefully erase the symptoms that plague you (without having to resort to more and more pills).  The following list of medications are those that can interfere with your heart-healthy nutrient, CoQ10 and therefore ubiquinol.  Read the list and see if you're medicine is on it.  I've tried to include as many international brand names as possible, but it helps if you know the "generic" name of your medicine. 
With many wishes for great health, here is the BIG LIST of:

Drug Muggers of CoQ10 and therefore, UBIQUINOL

Acebutolol (Sectral, Prent)
Acetohexamide (Diamox)
Acetophenazine (Tindal)
Amiloride and Hydrochlorothiazide (Moduretic)
Amitriptyline (Elavil)
Amoxapine (Ascendin)
Atenolol (Tenormin)
Atenolol and Chlorthalidone (Tenoretic)
Atorvastatin (Lipitor)
Benzthiazide (Exna)
Betaxolol (Betoptic eye drops, Kerlone)
Bisoprolol (Zebeta)
Candesartan and Hydrochlorothiazide (Atacand HCT)
Carteolol (Ocupress eye drops)
Carvedilol (Coreg)
Chlorothiazide (Diuril)
Chlorpromazine (Thorazine)
Chlorpropamide (Diabinese)
Clomipramine (Anafranil)
Clonidine (Catapres)
Cyclothiazide (Anhydron)
Desipramine (Imipramine)
Doxepin (Sinequan)
Droperidol (Inapsine)
Enalapril and Hydrochlorothiazide (Vaseretic)
Enoxacin (Penetrex)
Esmolol (Brevibloc)
Fenofibrate (Tricor)
Fluphenazine (Prolixin)
Fluvastatin (Lescol)
Gemfibrozil (Lopid)
Glimepiride (Amaryl)
Glipizide (Glucotrol, Glucotrol XL)
Glyburide (Micronase, DiaBeta, Euglucon)
Glyburide and Metformin (Glucovance)
Haloperidol (Haldol)
Hydralazine (Apresoline)
Hydralazine and Hydrochlorothiazide (Apresozide)
Hydralazine, Hydrochlorothiazide, and Reserpine (Ser-Ap-Es)
Hydrochlorothiazide or HCTZ  (Hydrodiuril)
Hydrochlorothiazide and Reserpine (Hydropres, Hydroserpine)
Hydrochlorothiazide and Spironolactone (Aldactazide)
Hydrochlorothiazide and Triamterene (Maxzide, Dyazide)
Hydroflumethiazide (Diucardin, Saluron)
Imipramine (Tofranil)
Indapamide (Lozol, Lozide, Apo-Indapamide)
Irbesartan and Hydrochlorothiazide (Avalide)
Labetalol (Normodyne, Trandate)
Losartan and Hydrochlorothiazide (Hyzaar)
Lovastatin (Mevacor, Apo-Lovastatin, Anlostin, Aztatin, Belvas)
Mesoridazine (Serentil)
Methdilazine (Bristaline, Dilosyn, Disyncram)
Methotrimeprazine (Apo-Methoprazine, Novo-Meprazine; Nozinan)
Methyclothiazide (Enduron, Aquatensen)
Methyldopa (Aldomet, Apo-Methyldopa)
Methyldopa and Hydrochlorothiazide (Aldoril, Apo-Methazide)
Metolazone (Zaroxolyn, Mykrox)
Metoprolol (Lopressor, Toprol XL, Apo-Metoprolol, Betaloc, Durules, PMS-Metoprolol)
Moexipril and Hydrochlorothiazide (Uniretic)
Nadolol (Corgard)
Nortriptyline (Pamelor)
Perphenazine (Trilafon)
Pindolol (Visken)
Polythiazide (Renese)
Pravastatin (Pravachol, Apo-Pravastatin)
Prazosin and Polythiazide (Minozide)
Prochlorperazine (Compazine)
Promazine (Sparine)
Promethazine (Phenergan)
Propafenone (Trental)
Propranolol (Inderal)
Propranolol and Hydrochlorothiazide (Inderide)
Protriptyline (Vivactil, Triptil)
Quinethazone (Hydromox)
Repaglinide (Prandin, GlucoNorm)
Simvastatin (Zocor, Apo-Simvastatin, Revastat, Simvacor, Lisac, Cardin)
Sotalol (Betapace, Alti-Sotalol)
Telmisartan and Hydrochlorothiazide (Micardis-HCT, Micardis Plus)
Thiethylperazine (Torecan)
Thioridazine (Mellaril, Apo-Thioridazine)
Timolol (Timoptic, Apo-Timol,
Tolazamide (Tolinase)
Tolbutamide (Apo-Tolbutamide, Diabetose)
Trichlormethiazide (Metahydrin, Naqua)
Trifluoperazine (Stelazine)
Valsartan and Hydrochlorothiazide (Diovan HCT)

This completes the list of drug muggers, updated January 15, 2009

If you think you are being mugged by one of these drugs, the best thing to do is to supplement with UBIQUINOL. A good place to start is with 100 - 200 mg per day. I have written much more on this subject. Just search the web to find more information if necessary. I hope this helps you.

These statements have not been evaluated by the Food and Drug Administration.  Any products mentioned or information within this column is not intended to diagnose, treat, cure or prevent any disease.


Ubiquinol a Breakthrough For People With Heart Disease, Liver Damage, And Cancer Concerns

Catalog Black Decker Grass Trimmer


Twitter Facebook Flickr RSS



Fran�ais Deutsch Italiano Portugu�s
Espa�ol ??? ??? ?????







Sponsor Links